Glycans in Drug Design


Glycans are elements of numerous bio-therapeutic mediators, ranging from natural products to molecules based on rational plan to recombinant glycoproteins. The glycan components of these agents can be important aspects of their biological activity and therapeutic efficacy. Biochemistry and Glycobiology includes a multidisciplinary study of carbohydrate-binding proteins (lectins), glycolipids and some selected other plant proteins that are skilful of connecting with endogenous or foreign (macro) molecules. The eminence of the research is on protein-carbohydrate interaction and their involvement in signalling procedures in plants or in plant protection. Based on the formed fundamental alertness new methods are being industrialised to shield crop plants against pests and diseases.


  • Membrane biophysics
  • Systems Biology
  • Enzyme synthesis
  • Biophysical approaches to cell biology
  • Computational and theoretical Biophysics

Related Conference of Glycans in Drug Design

May 04-05, 2026

7th International Conference on Drug Chemistry

Paris, France
September 03-04, 2026

16th World Glycobiology Congress

Aix-en-Provence, France
September 21-22, 2026

24th International Conference on Structural Biology

A Coruna, Spain

Glycans in Drug Design Conference Speakers